Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Safety and Tolerability Phase 1/2a Study of Two Dosing Regimens of EUR-1100 for Oral Use, in Subjects With Eosinophilic Esophagitis (EoE)
NCT01386112 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled, Safety and Tolerability Phase 1/2a Study of Two Dosing Regimens of EUR-1100 for Oral Use, in Subjects With Eosinophilic Esophagitis (EoE)
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- October 31, 2012
- Enrollment
- 24 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.